23 patents
Utility
Methods of Preventing Progression to Type 2 Diabetes Melitus
3 Feb 22
The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
Wesley DAY, Barbara TROUPIN
Filed: 15 Oct 21
Utility
Pharmaceutical Formulations
30 Dec 21
The present invention provides compositions and methods for the treatment or prevention of pulmonary hypertension comprising administering an ascomycin, or a pharmaceutically acceptable salt, solvate, analog, or prodrug thereof to the patient with pulmonary hypertension.
Narinder S. BANAIT, Leo GU
Filed: 9 Sep 21
Utility
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
9 Dec 21
Formulations are provided for the oral administration of avanafil, a Type V phosphodiesterase inhibitor (“PDE V inhibitor”), and analogs thereof.
Calvin Theodore BROMAN, Eric SHEU
Filed: 19 Aug 21
Utility
Low Dose Topiramate/phentermine Composition and Methods of Use Thereof
9 Dec 21
A method for effecting weight loss by administering a combination of topiramate and phentermine is provided.
Thomas NAJARIAN, Peter Y. TAM, Leland F. WILSON
Filed: 23 Aug 21
Utility
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
9 Dec 21
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
Thomas NAJARIAN, Peter Y. TAM, Leland F. WILSON
Filed: 23 Aug 21
Utility
Compositions and Methods for the Treatment or Prevention of Pulmonary Hypertension
4 Nov 21
The present invention provides compositions and methods for the treatment or prevention of pulmonary hypertension comprising administering an ascomycin, or a pharmaceutically acceptable salt, solvate, analog, or prodrug thereof to the patient with pulmonary hypertension.
Narinder S. BANAIT, Leo GU
Filed: 12 Jul 21
Utility
Methods of Treating Obesity In Responder and Non-responder Populations
16 Sep 21
The disclosed embodiments relate to, dosing regimens for the administration of topiramate, optionally in combination with one or more sympathomimetic agents such as phentermine.
Peter TAM, Roman DVORAK, Craig PETERSON
Filed: 28 May 21
Utility
Combination Therapy for Pulmonary Hypertension
2 Sep 21
The present invention provides compositions and methods for the treatment of pulmonary hypertension using combination therapy.
Leo Gu, Paul C. Nakagaki, Narinder S. Banait
Filed: 11 May 21
Utility
Treatment of Sleep Apnea with a Combination of a Carbonic Anhydrase Inhibitor and an Aldosterone Antagonist
3 Jun 21
This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS).
Charles H. BOWDEN, Craig PETERSON
Filed: 16 Feb 21
Utility
Pharmaceutical Formulations
22 Apr 21
The present invention provides compositions and methods for the treatment or prevention of pulmonary hypertension comprising administering an ascomycin, or a pharmaceutically acceptable salt, solvate, analog, or prodrug thereof to the patient with pulmonary hypertension.
Narinder S. BANAIT, Leo GU
Filed: 5 Jun 20
Utility
Orally Administrable Formulations for the Controlled Release of a Pharmacologically Active Agent
8 Jul 20
Drug tablets that include a controlled release layer of a moisture-sensitive active agent are prepared with a lipidic matrix forming excipient, a water-soluble, channel forming excipient and a filler, each being non-hygroscipic.
Calvin Theodore BROMAN, Eric SHEU
Filed: 17 Mar 20
Utility
Low Dose Topiramate/phentermine Composition and Methods of Use Thereof
17 Jun 20
A method for effecting weight loss by administering a combination of topiramate and phentermine is provided.
Thomas NAJARIAN, Peter Y. TAM, Leland F. WILSON
Filed: 19 Feb 20
Utility
Escalating Dosing Regimen for Effecting Weight Loss and Treating Obesity
17 Jun 20
The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se.
Thomas NAJARIAN, Peter Y. TAM, Leland F. WILSON
Filed: 19 Feb 20
Utility
Methods of Preventing Progression to Type 2 Diabetes Melitus
10 Jun 20
The present invention provides compositions and methods for delaying or preventing progression to type 2 diabetes mellitus in individuals with prediabetes and metabolic syndrome.
Wesley DAY, Barbara TROUPIN
Filed: 2 Jan 20
Utility
Combination Therapy for Effecting Weight Loss and Treating Obesity
29 Apr 20
Thomas NAJARIAN
Filed: 1 Jan 20
Utility
Methods of Regulating Access to Qsymia to Mitigate Potential Drug-associated Risks
29 Apr 20
The present invention provides methods for dispensing or distributing a drug, particularly a potentially teratogenic drug, to a patient while minimizing the occurrence of an adverse side effect.
Michael MILLER, Barbara TROUPIN
Filed: 1 Jan 20
Utility
Combination Therapy for Pulmonary Hypertension
4 Mar 20
The present invention provides compositions and methods for the treatment of pulmonary hypertension using combination therapy.
Leo GU, Paul C. NAKAGAKI, Narinder S. BANAIT
Filed: 10 Apr 19
Utility
Treatment of Sleep Apnea with a Combination of a Carbonic Anhydrase Inhibitor and an Aldosterone Antagonist
4 Mar 20
This invention relates generally to methods and pharmaceutical formulations useful in treating patients suffering from sleep apnea, including obstructive sleep apnea syndrome (OSAS).
Charles H. BOWDEN, Craig PETERSON
Filed: 7 Mar 19
Utility
Orally Disintegrating Dosage Form for Administration of Avanafil, and Associated Methods of Manufacture and Use
29 Jan 20
Formulations are provided for the oral administration of avanafil, a Type V phosphodiesterase inhibitor (“PDE V inhibitor”), and analogs thereof.
Calvin Theodore BROMAN, Eric SHEU
Filed: 1 Oct 19
Utility
Methods and Compositions for the Treatment of Non-alcoholic Steatohepatitis
11 Dec 19
The present disclosure relates to methods of preventing, treating, delaying the onset of, and delaying the progression of liver disease by administering topiramate in combination with phentermine to a patient in need thereof.
Craig Peterson
Filed: 17 Jan 19